Back to Search
ROBERT BUCHANAN, CDCA
CDCA
Addiction (Substance Use Disorder) Counselor
NPI: 1336003425Individual
Specialties, Licenses & Credentials
Counselor — Addiction (Substance Use Disorder)
Code: 101YA0400X
CDCA.194564(OH)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
3
With Results
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
NCT00176423COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
NCT00056498COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
NCT00492336COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (3)
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.
PMID 25368372·Schizophr Bull·2015
2-rct
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.
PMID 20664583·Neuropsychopharmacology·2010
4-observational
Galantamine for the treatment of cognitive impairments in people with schizophrenia.
PMID 17986678·Am J Psychiatry·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1724 S 3RD ST
IRONTON, OH 45638 - Phone
- (740) 442-7143
Quick Facts
- NPI
- 1336003425
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 3
Are you this provider?
Claim Your Profile